We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+3.25%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$1.34T
AUM Growth
+$27B
Cap. Flow
+$6.32B
Cap. Flow %
0.47%
Top 10 Hldgs %
24.3%
Holding
7,917
New
510
Increased
3,353
Reduced
2,466
Closed
523

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.21B
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$2.24B
3
DIS icon
Walt Disney
DIS
+$2.18B
4
WMT icon
Walmart Inc
WMT
+$1.96B
5
MCD icon
McDonald's
MCD
+$1.91B

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Financials 10.12%
3 Consumer Discretionary 9.84%
4 Healthcare 7.97%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBAR icon
6276
BBVA Argentina
BBAR
$3.18B
$4.88K ﹤0.01%
256
CCD
6277
Calamos Dynamic Convertible & Income Fund
CCD
$753M
$4.86K ﹤0.01%
+200
New +$4.91K
DGRE icon
6278
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$150M
$4.85K ﹤0.01%
193
-4
-2% -$105
SJB icon
6279
ProShares Short High Yield
SJB
$47.6M
$4.84K ﹤0.01%
300
-100
-25% -$1.63K
ASBPW
6280
Aspire Biopharma Warrant
ASBPW
$442K
0
AVK
6281
Advent Convertible and Income Fund
AVK
$572M
$4.71K ﹤0.01%
400
WHWK
6282
Whitehawk Therapeutics
WHWK
$256M
$4.66K ﹤0.01%
1,478
-2,759
-65% -$6.25K
GAUG icon
6283
FT Vest US Equity Moderate Buffer ETF August
GAUG
$293M
$4.66K ﹤0.01%
132
-778
-85% -$27.4K
GOSS icon
6284
Gossamer Bio
GOSS
$79.8M
$4.65K ﹤0.01%
5,138
+4,444
+640% +$3.81K
UCIB icon
6285
ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038
UCIB
$33.9M
$4.64K ﹤0.01%
180
FJUN icon
6286
FT Vest US Equity Buffer ETF June
FJUN
$1.4B
$4.62K ﹤0.01%
90
-11,841
-99% -$608K
GDV icon
6287
Gabelli Dividend & Income Trust
GDV
$2.7B
$4.59K ﹤0.01%
190
SEPT icon
6288
AllianzIM U.S. Equity Buffer10 Sep ETF
SEPT
$33.5M
$4.53K ﹤0.01%
148
-2,885
-95% -$88.2K
IIM icon
6289
Invesco Value Municipal Income Trust
IIM
$601M
$4.45K ﹤0.01%
374
IBTH icon
6290
iShares iBonds Dec 2027 Term Treasury ETF
IBTH
$2.28B
$4.44K ﹤0.01%
+200
New +$4.46K
EDIV icon
6291
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$4.41K ﹤0.01%
125
-4,000
-97% -$145K
IMRX icon
6292
Immuneering
IMRX
$325M
$4.34K ﹤0.01%
1,974
-450
-19% -$933
DBE icon
6293
Invesco DB Energy Fund
DBE
$90.5M
$4.19K ﹤0.01%
226
-790
-78% -$15.1K
JANT icon
6294
AllianzIM U.S. Equity Buffer10 Jan ETF
JANT
$62.1M
$4.18K ﹤0.01%
116
-1,674
-94% -$59.6K
CVM icon
6295
CEL-SCI Corp
CVM
$28.5M
$4.18K ﹤0.01%
348
+339
+3,767% +$7.82K
PJUL icon
6296
Innovator US Equity Power Buffer ETF July
PJUL
$1.29B
$4.18K ﹤0.01%
101
-3,528
-97% -$145K
EBS icon
6297
Emergent Biosolutions
EBS
$232M
$4.15K ﹤0.01%
434
-209
-33% -$1.92K
RVT icon
6298
Royce Value Trust
RVT
$2.33B
$4.15K ﹤0.01%
262
+23
+10% +$367
AIO
6299
Virtus Artificial Intelligence & Technology Opportunities Fund
AIO
$918M
$4.14K ﹤0.01%
168
-66
-28% -$1.54K
CAAS icon
6300
China Automotive Systems
CAAS
$139M
$4.14K ﹤0.01%
1,009
-882
-47% -$3.85K

Similar funds

JP Morgan Chase's Q4 2024 Portfolio in Review

As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.

JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
  • JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
  • JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
  • JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
  • JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
  • JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
  • JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.